Related Experiment Video
Updated: Feb 9, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Brucella and peritoneal dialysis related peritonitis: case report and review of literature
Abstract:
Isolated case reports of peritonitis due to Brucella spp. during peritoneal dialysis (PD) continue to surface in the medical literature. However, the optimal treatment regimen for these patients, in particular with regards to the fate of PD catheter, is still largely unknown. We report a case of brucella peritonitis successfully treated with intraperitoneal administration of amikacin, along with oral rifampicin and doxycycline but without catheter removal. Furthermore, we have reviewed the literature up until present day.
Insights
Brucella peritonitis in peritoneal dialysis (PD) patients can be treated effectively without removing the PD catheter. Intraperitoneal amikacin combined with oral antibiotics offers a successful treatment strategy for Brucella peritonitis during PD.
Area of Science:
- Nephrology
- Infectious Diseases
- Microbiology
Background:
- Peritonitis is a serious complication for patients undergoing peritoneal dialysis (PD).
- Brucella species are an uncommon but reported cause of infectious peritonitis in PD patients.
- Optimal management strategies, particularly regarding the peritoneal dialysis catheter, remain unclear.
Observation:
- A case of Brucella peritonitis in a PD patient was observed.
- The patient was treated with intraperitoneal amikacin and oral rifampicin and doxycycline.
- The peritoneal dialysis catheter was intentionally left in place during treatment.
Findings:
- Successful resolution of Brucella peritonitis was achieved.
- Treatment involved a combination of intraperitoneal and oral antibiotics.
- The peritoneal dialysis catheter was preserved, avoiding the need for removal and reinsertion.
Implications:
- This case suggests that PD catheter removal may not be necessary for treating Brucella peritonitis.
- Intraperitoneal amikacin combined with oral agents could be an effective therapeutic option.
- Further research and case reviews are warranted to establish definitive treatment guidelines for Brucella peritonitis in PD patients.
Related Concept Videos
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis

